Literature DB >> 21837140

1,1'-(Piperazine-1,4-di-yl)dipropan-2-ol.

Murat Türkyılmaz, Yakup Baran, Namık Ozdemir.   

Abstract

The asymmetric unit of the crystal contains one-fourth of the title compound, C(10)H(22)N(2)O(2), with the centre of the piperazine ring located at a site of 2/m symmetry. The piperazine ring adopts a chair conformation. The methine and methylene C atoms of the 2-hydroxypropyl groups show symmetry-imposed disorder over two equally occupied and mutually exclusive sets of positions. Only intra-molecular O-H⋯N contacts are observed.

Entities:  

Year:  2011        PMID: 21837140      PMCID: PMC3152060          DOI: 10.1107/S1600536811023397

Source DB:  PubMed          Journal:  Acta Crystallogr Sect E Struct Rep Online        ISSN: 1600-5368


Related literature

For the biological properties of piperazine compounds, see: Foroumadi et al. (2007 ▶); Upadhayaya et al. (2004 ▶); Chen et al. (2006 ▶); Cunico et al. (2009 ▶); Smits et al. (2008 ▶); Penjišević et al. (2007 ▶); Becker et al. (2006 ▶). For hydrogen-bond graph-set motifs, see: Bernstein et al. (1995 ▶). For ring puckering parameters, see: Cremer & Pople (1975 ▶).

Experimental

Crystal data

C10H22N2O2 M = 202.30 Monoclinic, a = 13.838 (10) Å b = 7.791 (5) Å c = 5.543 (4) Å β = 97.26 (3)° V = 592.8 (7) Å3 Z = 2 Mo Kα radiation μ = 0.08 mm−1 T = 273 K 0.40 × 0.25 × 0.10 mm

Data collection

Rigaku R-AXIS RAPID diffractometer 2493 measured reflections 604 independent reflections 441 reflections with I > 2σ(I) R int = 0.139

Refinement

R[F 2 > 2σ(F 2)] = 0.052 wR(F 2) = 0.119 S = 1.05 604 reflections 46 parameters 14 restraints H-atom parameters constrained Δρmax = 0.28 e Å−3 Δρmin = −0.34 e Å−3 Data collection: PROCESS-AUTO (Rigaku, 1998 ▶); cell refinement: PROCESS-AUTO; data reduction: CrystalStructure (Rigaku/MSC, 2004 ▶); program(s) used to solve structure: SHELXS97 (Sheldrick, 2008 ▶); program(s) used to refine structure: SHELXL97 (Sheldrick, 2008 ▶); molecular graphics: ORTEP-3 for Windows (Farrugia, 1997 ▶); software used to prepare material for publication: WinGX (Farrugia, 1999 ▶) and PLATON (Spek, 2009 ▶). Crystal structure: contains datablock(s) I, global. DOI: 10.1107/S1600536811023397/fy2011sup1.cif Structure factors: contains datablock(s) I. DOI: 10.1107/S1600536811023397/fy2011Isup2.hkl Supplementary material file. DOI: 10.1107/S1600536811023397/fy2011Isup3.cml Additional supplementary materials: crystallographic information; 3D view; checkCIF report
C10H22N2O2F(000) = 224
Mr = 202.30Dx = 1.133 Mg m3
Monoclinic, C2/mMo Kα radiation, λ = 0.71073 Å
Hall symbol: -C 2yCell parameters from 3092 reflections
a = 13.838 (10) Åθ = 3.0–30.0°
b = 7.791 (5) ŵ = 0.08 mm1
c = 5.543 (4) ÅT = 273 K
β = 97.26 (3)°Prism, colourless
V = 592.8 (7) Å30.40 × 0.25 × 0.10 mm
Z = 2
Rigaku R-AXIS RAPID diffractometer441 reflections with I > 2σ(I)
Radiation source: fine-focus sealed tubeRint = 0.139
graphiteθmax = 25.5°, θmin = 3.0°
Detector resolution: 10.00 pixels mm-1h = −16→16
ω scansk = −9→9
2493 measured reflectionsl = −5→6
604 independent reflections
Refinement on F2Primary atom site location: structure-invariant direct methods
Least-squares matrix: fullSecondary atom site location: difference Fourier map
R[F2 > 2σ(F2)] = 0.052Hydrogen site location: inferred from neighbouring sites
wR(F2) = 0.119H-atom parameters constrained
S = 1.05w = 1/[σ2(Fo2) + (0.0375P)2 + 0.2898P] where P = (Fo2 + 2Fc2)/3
604 reflections(Δ/σ)max < 0.001
46 parametersΔρmax = 0.28 e Å3
14 restraintsΔρmin = −0.34 e Å3
Geometry. All e.s.d.'s (except the e.s.d. in the dihedral angle between two l.s. planes) are estimated using the full covariance matrix. The cell e.s.d.'s are taken into account individually in the estimation of e.s.d.'s in distances, angles and torsion angles; correlations between e.s.d.'s in cell parameters are only used when they are defined by crystal symmetry. An approximate (isotropic) treatment of cell e.s.d.'s is used for estimating e.s.d.'s involving l.s. planes.
Refinement. Refinement of F2 against ALL reflections. The weighted R-factor wR and goodness of fit S are based on F2, conventional R-factors R are based on F, with F set to zero for negative F2. The threshold expression of F2 > σ(F2) is used only for calculating R-factors(gt) etc. and is not relevant to the choice of reflections for refinement. R-factors based on F2 are statistically about twice as large as those based on F, and R- factors based on ALL data will be even larger.
xyzUiso*/UeqOcc. (<1)
O10.78313 (12)0.50000.4674 (3)0.0706 (7)
H10.72970.51970.39070.106*0.50
N10.60084 (15)0.50000.5912 (4)0.0715 (7)
C10.86326 (18)0.50000.8733 (5)0.0754 (9)
H1A0.91690.43900.81970.113*0.50
H1B0.85730.46901.03840.113*0.50
H1C0.87460.62130.86400.113*0.50
C20.7712 (2)0.4545 (5)0.7137 (5)0.0603 (12)0.50
H20.75970.33070.72330.072*0.50
C30.6841 (2)0.5495 (5)0.7803 (6)0.0609 (11)0.50
H3A0.69520.67240.77820.073*0.50
H3B0.67050.51660.94130.073*0.50
C40.54111 (14)0.6506 (3)0.6021 (3)0.0751 (7)
H4A0.58060.75260.59170.090*
H4B0.51500.65330.75650.090*
U11U22U33U12U13U23
O10.0609 (11)0.0975 (15)0.0541 (11)0.0000.0103 (8)0.000
N10.0463 (11)0.118 (2)0.0498 (12)0.0000.0031 (9)0.000
C10.0527 (15)0.103 (2)0.0677 (17)0.000−0.0030 (13)0.000
C20.0519 (15)0.075 (3)0.0533 (16)0.0024 (15)0.0027 (13)−0.0010 (15)
C30.0483 (14)0.084 (3)0.0490 (14)0.0021 (14)0.0016 (12)−0.0047 (14)
C40.0807 (13)0.0883 (15)0.0563 (11)−0.0195 (11)0.0084 (9)−0.0038 (11)
O1—C2i1.440 (4)C1—H1B0.9600
O1—C21.440 (4)C1—H1C0.9600
O1—H10.8200C2—C31.499 (4)
N1—C4i1.441 (3)C2—H20.9800
N1—C41.441 (3)C3—H3A0.9700
N1—C31.507 (3)C3—H3B0.9700
N1—C3i1.507 (3)C4—C4ii1.500 (4)
C1—C21.499 (4)C4—H4A0.9700
C1—C2i1.499 (4)C4—H4B0.9700
C1—H1A0.9600
C2i—O1—H1103.9O1—C2—C3107.7 (2)
C2—O1—H1109.5C1—C2—C3112.8 (3)
C4i—N1—C4109.0 (2)O1—C2—H2109.4
C4i—N1—C3124.8 (2)C1—C2—H2109.4
C4—N1—C398.90 (17)C3—C2—H2109.4
C4i—N1—C3i98.90 (17)C2—C3—N1105.7 (2)
C4—N1—C3i124.8 (2)C2—C3—H3A110.6
C2—C1—H1A109.5N1—C3—H3A110.6
C2i—C1—H1A124.6C2—C3—H3B110.6
C2—C1—H1B109.5N1—C3—H3B110.6
C2i—C1—H1B116.9H3A—C3—H3B108.7
H1A—C1—H1B109.5N1—C4—C4ii110.64 (15)
C2—C1—H1C109.5N1—C4—H4A109.5
C2i—C1—H1C82.4C4ii—C4—H4A109.5
H1A—C1—H1C109.5N1—C4—H4B109.5
H1B—C1—H1C109.5C4ii—C4—H4B109.5
O1—C2—C1108.1 (2)H4A—C4—H4B108.1
C2i—O1—C2—C1−70.1 (2)C4i—N1—C3—C285.4 (3)
C2i—O1—C2—C352.0 (2)C4—N1—C3—C2−153.8 (2)
C2i—C1—C2—O169.7 (2)C3i—N1—C3—C252.8 (3)
C2i—C1—C2—C3−49.2 (3)C4i—N1—C4—C4ii−58.1 (3)
O1—C2—C3—N156.3 (3)C3—N1—C4—C4ii170.2 (2)
C1—C2—C3—N1175.4 (2)C3i—N1—C4—C4ii−174.2 (2)
D—H···AD—HH···AD···AD—H···A
O1—H1···N10.822.222.696 (3)117
Table 1

Hydrogen-bond geometry (Å, °)

D—H⋯AD—HH⋯ADAD—H⋯A
O1—H1⋯N10.822.222.696 (3)117
  9 in total

1.  An integrated in silico 3D model-driven discovery of a novel, potent, and selective amidosulfonamide 5-HT1A agonist (PRX-00023) for the treatment of anxiety and depression.

Authors:  Oren M Becker; Dale S Dhanoa; Yael Marantz; Dongli Chen; Sharon Shacham; Srinivasa Cheruku; Alexander Heifetz; Pradyumna Mohanty; Merav Fichman; Anurag Sharadendu; Raphael Nudelman; Michael Kauffman; Silvia Noiman
Journal:  J Med Chem       Date:  2006-06-01       Impact factor: 7.446

2.  A short history of SHELX.

Authors:  George M Sheldrick
Journal:  Acta Crystallogr A       Date:  2007-12-21       Impact factor: 2.290

3.  The synthesis of L-carvone and limonene derivatives with increased antiproliferative effect and activation of ERK pathway in prostate cancer cells.

Authors:  Jiaojiao Chen; Min Lu; Yongkui Jing; Jinhua Dong
Journal:  Bioorg Med Chem       Date:  2006-06-27       Impact factor: 3.641

4.  Synthesis and antibacterial activity of levofloxacin derivatives with certain bulky residues on piperazine ring.

Authors:  Alireza Foroumadi; Saeed Emami; Shahla Mansouri; Azita Javidnia; Nosratollah Saeid-Adeli; Farshad H Shirazi; Abbas Shafiee
Journal:  Eur J Med Chem       Date:  2007-01-14       Impact factor: 6.514

5.  1-cinnamyl-4-(2-methoxyphenyl)piperazines: synthesis, binding properties, and docking to dopamine (D(2)) and serotonin (5-HT(1A)) receptors.

Authors:  Jelena Penjisević; Vladimir Sukalović; Deana Andrić; Sladjana Kostić-Rajacić; Vukić Soskić; Goran Roglić
Journal:  Arch Pharm (Weinheim)       Date:  2007-09       Impact factor: 3.751

6.  Optically active antifungal azoles: synthesis and antifungal activity of (2R,3S)-2-(2,4-difluorophenyl)-3-(5-[2-[4-aryl-piperazin-1-yl]-ethyl]-tetrazol-2-yl/1-yl)-1-[1,2,4]-triazol-1-yl-butan-2-ol.

Authors:  Ram Shankar Upadhayaya; Neelima Sinha; Sanjay Jain; Nawal Kishore; Ramesh Chandra; Sudershan K Arora
Journal:  Bioorg Med Chem       Date:  2004-05-01       Impact factor: 3.641

7.  Fragment based design of new H4 receptor-ligands with anti-inflammatory properties in vivo.

Authors:  Rogier A Smits; Herman D Lim; Agnes Hanzer; Obbe P Zuiderveld; Elena Guaita; Maristella Adami; Gabriella Coruzzi; Rob Leurs; Iwan J P de Esch
Journal:  J Med Chem       Date:  2008-03-22       Impact factor: 7.446

8.  Synthesis and antimalarial activity of hydroxyethylpiperazine derivatives.

Authors:  Wilson Cunico; Claudia R B Gomes; Marcele Moreth; Diogo P Manhanini; Isabela H Figueiredo; Carmen Penido; Maria G M O Henriques; Fernando P Varotti; Antoniana U Krettli
Journal:  Eur J Med Chem       Date:  2008-04-29       Impact factor: 6.514

9.  Structure validation in chemical crystallography.

Authors:  Anthony L Spek
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2009-01-20
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.